Rituximab and Belimumab Combination Therapy in PR3 Vasculitis

NCT03967925 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

ANCA Associated Vasculitis
Granulomatosis With Polyangiitis

Interventions

DRUG: Belimumab
DRUG: Rituximab
DRUG: Prednisolone

Sponsor

Rachel Jones

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]